Shop All LifeSign

Status COVID-19/Flu A&B Rapid Combination Test

4.9
| TRUSTED BY 50,000+
Regular price $395.00
Sale price $395.00 Regular price
Unit price
Sale
  • 25 Tests per Box
  • Test type: Lateral flow immunoassay
  • Specimen type: Anterior nasal or nasopharyngeal swab specimens
  • Turnaround time: 15-20 minutes
  • FDA status: Emergency Use Authorization (EUA) Granted
  • CLIA complexity: Waived
Free Shipping over $250. Get it shipped today.

Pro-Tip

If you're using the Status™ COVID-19/Flu A&B Rapid Combination Test to check for respiratory infections, consider adding the Status™ Strep A Plus Test to your health toolkit. This easy-to-use test helps you quickly detect strep throat, ensuring you don’t miss a potential diagnosis. By pairing both tests, you can efficiently monitor for multiple illnesses and take quick action, helping you manage your health with confidence.

Status™ COVID-19/Flu A&B Rapid Combination Test

Status™ COVID-19/Flu A&B Rapid Combination Test

Improving the quality of life.

LifeSign is a medical diagnostic company delivering high quality rapid point of care testing solutions to caregivers in critical care, physicians’ offices, schools, ships, ambulances, the workplace, criminal justice and the home. Our products are developed and manufactured under ISO, FDA cGMP, and CE mark guidelines, and marketed and supported with the highest of quality standards by LifeSign's team of Sales, Technical, and Customer Service professionals. Our mission and commitment is to improve the quality of life within our global community by providing high quality testing solutions to care providers.

Frequently asked questions

Find clear, helpful answers to the most common questions about Status™ COVID-19/Flu A&B Rapid Combination Test.

Still need help? Chat with us.

This test can detect the presence of COVID-19, influenza A, and influenza B.

A negative result could be due to an antigen level below the test's detection limit, or if the sample was collected or transported incorrectly.

A positive result doesn't rule out co-infections with other pathogens. It also doesn't identify specific influenza A subtypes or differentiate between SARS-CoV and SARS-CoV-2.

If you need to differentiate between specific strains of influenza A or SARS, you should consult with your local or state public health department.

Recently Viewed Products

About LifeSign
Rapid Diagnostics for Confident Clinical Decisions
LifeSign® Medical provides reliable point-of-care diagnostic solutions designed to support fast, accurate decision-making in clinical settings. From cardiac markers to drug testing and infectious disease detection, LifeSign equips healthcare professionals with tools they can trust. Empower your clinical team with dependable diagnostics that deliver results when every second counts. Choose Pharmalynk for LifeSign®, trusted tools for professionals, delivered by a name you can count on.
LifeSign image